Financial toxicity and contralateral prophylactic mastectomy: an analysis using propensity score methods.

Breast Cancer Research and Treatment
Malke AsaadAnaeze C Offodile

Abstract

Contralateral prophylactic mastectomy (CPM) is increasingly performed in average-risk patients despite the lack of survival benefit. In an era of heightened awareness of healthcare costs, we sought to determine the impact of CPM on financial toxicity in breast cancer. A single-institution propensity-matched analysis of female patients who underwent unilateral mastectomy (UM) with or without CPM for breast cancer over an 18-month period. Patients with a history of genetic predisposition or bilateral cancer were excluded. The validated Comprehensive Score for financial Toxicity (COST) evaluated financial toxicity among participants. Multivariable regression analysis evaluated the relationship between CPM and financial toxicity. Relevant domains of the Breast Q and SF12 instruments were examined as secondary outcomes. Sensitivity analysis was performed using propensity-weighting to examine robustness of results and increase our sample size. Overall, 104 patients were identified, equally distributed across UM and CPM. CPM was not associated with financial toxicity, as evidenced by comparable COST scores (adjusted difference, 1.53 [- 3.24 to 6.29]). Minor complications were significantly lower in UM patients (UM, 8%; CPM, 31%). CPM ...Continue Reading

References

Sep 24, 1999·Annals of Surgical Oncology·L L MontgomeryP I Borgen
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly MetcalfeSteven A Narod
Nov 17, 2005·Journal of the National Cancer Institute. Monographs·Larissa NekhlyudovAnn M Geiger
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann M GeigerSuzanne W Fletcher
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Todd M TuttleBeth A Virnig
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Todd M TuttleBeth A Virnig
Jul 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J MeropolUNKNOWN American Society of Clinical Oncology
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
Mar 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hazel B NicholsWilliam F Anderson
Nov 2, 2011·The Breast : Official Journal of the European Society of Mastology·Monica Morrow
Jun 15, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dmytro UnukovychYvonne Brandberg
Jul 23, 2013·Annals of Surgical Oncology·Megan E MillerKatharine Yao
Mar 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reshma JagsiSarah T Hawley
May 9, 2014·Annals of Surgical Oncology·Ashish A DeshmukhAbenaa M Brewster
May 23, 2014·JAMA Surgery·Shoshana M Rosenberg, Ann H Partridge
May 23, 2014·JAMA Surgery·Sarah T HawleySteven J Katz
May 29, 2014·Journal of Oncology Practice·Kathleen M FennAnees B Chagpar
Jun 4, 2014·Cancer·Scott E RegenbogenArden M Morris
Jul 23, 2014·Annals of Surgical Oncology·Dustin L EckSarah A McLaughlin
Sep 4, 2014·JAMA : the Journal of the American Medical Association·Allison W KurianScarlett L Gomez
Sep 6, 2014·Annals of Surgical Oncology·Andrea M CovelliFrances C Wright
Jan 27, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott D RamseyPolly Newcomb
Mar 10, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Shelley HwangDunya M Atisha
Jun 28, 2016·Plastic and Reconstructive Surgery·Patrick J BuchananAdeyiza O Momoh
Jul 7, 2016·International Journal of Women's Health·Katharine YaoIsabelle Bedrosian

❮ Previous
Next ❯

Citations

Aug 28, 2021·Journal of the American College of Surgeons·Tasha M Hughes, Lesly A Dossett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.